Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2014
04/24/2014US20140112932 Methods for Treating GI Syndrome and Graft versus Host Disease
04/24/2014US20140112929 Tumour necrosis factor receptor 1 antagonists
04/24/2014US20140112926 Fc VARIANTS
04/24/2014US20140112923 Epitope and its use of hepatitis b virus surface antigen
04/24/2014US20140112920 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
04/24/2014US20140112919 Interleukin-10 antibodies
04/24/2014US20140112918 Synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck
04/24/2014US20140112912 Diagnosis and treatment of autoantibody-mediated heart disease
04/24/2014US20140112911 Novel anti-cmet antibody
04/24/2014US20140112884 Composition and method for treating cancer
04/24/2014US20140112883 Methods for reducing an adverse immune response to a foreign antigen in a human subject with anti-cd4 antibodies or cd4-binding fragments thereof or cd4-binding molecules
04/24/2014CA2874979A1 Antigen binding proteins that bind dll-4
04/23/2014EP2722343A1 ANTI-erbB3 ANTIBODY
04/23/2014EP2722342A1 Methods and compositions for the treatment of pancreatic cancer
04/23/2014EP2722341A1 Antibodies to interleukin-6 and uses thereof
04/23/2014EP2722336A1 Vaccine for the prevention of breast cancer relapse
04/23/2014EP2722056A1 CT062, a Chlamydia antigen
04/23/2014EP2722055A1 Combination therapy with antibodies and anti-VEGF agents for the treatment of cancer
04/23/2014EP2721071A1 Tem8 antibodies, conjugates thereof, and their use
04/23/2014EP2721068A1 Selective elimination of erosive cells
04/23/2014EP2721066A1 Tumour necrosis factor receptor 1 antagonists
04/23/2014EP2721065A1 Anti-angptl3 antibodies and uses thereof
04/23/2014EP2721051A1 A method for the production of hydrolyzed allergens
04/23/2014EP2720721A1 Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer
04/23/2014EP2720720A1 Combination therapy to prevent dcis formation and progression to breast cancer
04/23/2014EP2720719A2 Method of selecting therapeutic indications
04/23/2014EP2720718A2 Anti-cd3 therapies
04/23/2014EP2720717A1 Vaccine adjuvant composition comprising inulin particles
04/23/2014EP2720716A1 Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
04/23/2014EP2720715A1 Vaccine composition comprising an inactivated chikungunya virus strain
04/23/2014EP2720714A2 Methods of treating and preventing staphylococcus aureus infections and associated conditions
04/23/2014EP2720708A2 Targeting the neuromuscular junction for treatment
04/23/2014EP2720706A2 Group a streptococcus multivalent vaccine
04/23/2014CN103748114A Bispecific t cell activating antigen binding molecules
04/23/2014CN103748113A Modulators of plexin b2 activity
04/23/2014CN103748112A Antibodies for treatment of cancer expressing claudin 6
04/23/2014CN103748111A Anti-cgrp compositions and use thereof
04/23/2014CN103748105A A method for the production of hydrolyzed allergens
04/23/2014CN103748103A Methods for preparation of glycosphingolipids and uses thereof
04/23/2014CN103747803A Anti-AXL antibodies and uses thereof
04/23/2014CN103747802A Methods for increasing efficacy of folr1 cancer therapy
04/23/2014CN103747801A Anti-emr1 antibodies
04/23/2014CN103747800A Liquid vaccine preparations
04/23/2014CN103747799A Cytotoxic t cell inducer
04/23/2014CN103747798A Protein matrix vaccine compositions including polycations
04/23/2014CN103747797A Liposomal formulations
04/23/2014CN103747787A Substituted 2-benzylidene-2h-benzo[b][1,4]thiazin-3(4h)-ones, derivatives thereof, and therapeutic uses thereof
04/23/2014CN103740759A Recombinant turkey herpesvirus of expressing H5N1subtype avian influenza virus HA gene
04/23/2014CN103740758A Recombinant baculovirus vector, virus like particle, preparation method and use
04/23/2014CN103740743A Recombined rhabdovirus for expressing porcine bocavirus VP2 protein and application thereof
04/23/2014CN103740741A HPV18 E and E7 fusion gene mutant as well as related biological material and coding protein thereof
04/23/2014CN103740736A Chemically synthesized gene segment of gE (glycoprotein E) extracellular domain of HSV2 (herpes simplex virus) as well as expression method and application thereof
04/23/2014CN103740735A Gene segment in extracellular region of chemosynthetic HSV2 (Herpes Simplex Virus Type 2) virus gC glycoprotein as well as expression and application of gene segment
04/23/2014CN103740656A Method for purifying recombined hansenula polymorpha hepatitis E virus-like particles and application
04/23/2014CN103740655A H5N1 avian influenza virus-like particle, application and preparation method of virus-like particle, and vaccine
04/23/2014CN103740654A Cold adaptation strain of influenza B virus Vero cell and application thereof
04/23/2014CN103740653A Porcine transmissible gastroenteritis virus and application thereof
04/23/2014CN103740650A Monoclonal antibody BTV16-3G10 resistant to bluetongue virus serum 16 type VP2 protein, B-cell epitope polypeptide identified by monoclonal antibody BTV16-3G10, and applications of monoclonal antibody BTV16-3G10
04/23/2014CN103740649A Monoclonal antibody BTV16-2B4 resistant to bluetongue virus serum 16 type VP2 protein, B-cell epitope identified by monoclonal antibody BTV16-2B4, and applications of monoclonal antibody BTV16-2B4
04/23/2014CN103740648A Kinesin spindle protein (Eg5) monoclonal antibody and hybridoma cell strain secreting it
04/23/2014CN103740632A Recombinant Escherichia coli and application thereof in preparation of anti-O157:H7 N-glycoprotein vaccine
04/23/2014CN103740625A Pig mycoplasma pneumonia live attenuated vaccine and application thereof
04/23/2014CN103739717A Recombinant protein subunit vaccine for resisting porcine circovirus serotype 2
04/23/2014CN103739711A High affinity human antibodies to human ill-4 receptor
04/23/2014CN103739710A VEGF (Vascular Endothelial Growth Factor) resistant antibody and application thereof
04/23/2014CN103739709A Antibodies against human angiopoietin 2
04/23/2014CN103739707A Humanized antibody for resisting avian influenza H5N1 hemagglutinin antigen, and preparation method and application thereof
04/23/2014CN103739682A Protein with immunogenicity on cervical cancer and application thereof
04/23/2014CN103736100A Novel microbicide anhydride modified anti-SEVI (semen-derived enhancer of viral infection) polyclonal antibody for preventing HIV (human immunodeficiency virus) sexual transmission
04/23/2014CN103736091A Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents
04/23/2014CN103736090A Methanesulfonic acid deferoxamine adjuvant and vaccine comprising methanesulfonic acid deferoxamine adjuvant
04/23/2014CN103736089A Human diploid cell cultured rabies vaccine and preparation method thereof
04/23/2014CN103736088A Avian influenza H9 subtype inactivated vaccine, preparation method and application thereof
04/23/2014CN103736087A Method for removing split agent in virus split vaccine
04/23/2014CN103736086A A method for enhancing t cell response
04/23/2014CN103735825A Comprehensive conditioning traditional Chinese medicine composition and application thereof
04/23/2014CN103735521A Animal lyophilized inactivated vaccine and preparation process thereof
04/23/2014CN103191425B Combination medicine containing rituximab and lightyellow sophora root
04/23/2014CN103159834B Sendai virus antigen peptide and application thereof in detecting Sendai virus infection
04/23/2014CN103007289B Heat-resisting protective agent for duck virus hepatitis live vaccines and preparation method and application of protective agent
04/23/2014CN102895660B Bivalent inactivated vaccine for duck virus hepatitis
04/23/2014CN102816222B Chicken E.tenella MA2 gene, vector, recombinant strain, protein, and application thereof
04/23/2014CN102793913B Tumor vaccine of recombinant murine EPS8 gene, and preparation method and application thereof
04/23/2014CN102697705B Liposome gel preparation and preparation method and application thereof
04/23/2014CN102559613B Malignant malaria vaccine and preparation method thereof
04/23/2014CN102548554B Method for treating Th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
04/23/2014CN102260322B Antigen peptide of Helicobacter pylori and application thereof
04/23/2014CN102239251B Bovine viral diarrhea virus with a modified ERNS protein
04/23/2014CN102238960B Process for production of vaccines
04/23/2014CN101815527B Capsule composition for use as immunogen against campylobacter jejuni
04/23/2014CN101605559B Treatment of immune disease by mucosal delivery of antigens
04/23/2014CN101325968B Anti-CTLA-4 antibody compositions
04/22/2014US8703930 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
04/22/2014US8703921 Compositions and methods for delivering inhibitory oligonucleotides
04/22/2014US8703920 Fully human antibodies against N-cadherin
04/22/2014US8703918 Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof
04/22/2014US8703908 Expression and export of angiogenesis inhibitors as immunofusins
04/22/2014US8703733 Humanized TTC and methods of use thereof
04/22/2014US8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
04/22/2014US8703714 Monomethylvaline compounds capable of conjugation to ligands
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 1823